Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Here's How Much $1000 Invested In Enphase Energy 10 Years Ago Would Be Worth Today

Enphase Energy (NASDAQ:ENPH) has outperformed the market over the past 10 years by 27.59% on an annualized basis producing an average annual return of 38.44%. Currently, Enphase Energy has a market capitalization of $24.47 billion.

Benzinga

Here's How Mizuho Views AMD, Nvidia, Qualcomm

Mizuho analyst Vijay Rakesh included Gigabyte, a distributor of GPUs and a motherboard OEM, and Zhen Ding, a leading PCB supplier in coverage post-Asia tech series checks.

Benzinga

Earnings Outlook For Motorcar Parts of America

Motorcar Parts of America (NASDAQ:MPAA) is set to give its latest quarterly earnings report on Tuesday, 2022-06-14. Here's what investors need to know before the announcement. Analysts estimate that Motorcar Parts of America will report an earnings per share (EPS) of $0.47.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Journey Medical Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Journey Medical's (NASDAQ:DERM) reported sales totaled $23.30 million. Despite a 93.66% increase in earnings, the company posted a loss of $1.38 million.

Benzinga

BRP Group's Return On Capital Employed Insights

According to Benzinga Pro, during Q1, BRP Group (NASDAQ:BRP) earned $44.84 million, a 200.97% increase from the preceding quarter. BRP Group also posted a total of $242.85 million in sales, a 52.54% increase since Q4.

Benzinga

The RealReal's Return On Capital Employed Insights

The RealReal (NASDAQ:REAL) brought in sales totaling $146.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 10.0%, resulting in a loss of $57.41 million.

Benzinga

Sera Prognostics Earnings Perspective: Return On Capital Employed

According to data from Benzinga Pro, during Q1, Sera Prognostics's (NASDAQ:SERA) reported sales totaled $38.00 thousand. Despite a 2.21% increase in earnings, the company posted a loss of $12.21 million.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

BTRS Holdings Earnings Perspective: Return On Capital Employed

Benzinga Pro data, BTRS Holdings (NASDAQ:BTRS) reported Q1 sales of $45.63 million. Earnings fell to a loss of $29.03 million, resulting in a 76.18% decrease from last quarter.

Benzinga

Why AMD Stock Is Trading Lower Today

Advanced Micro Devices Inc (NASDAQ: AMD) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

Revance Therapeutics's Return On Capital Employed Insights

Benzinga Pro data, Revance Therapeutics (NASDAQ:RVNC) reported Q1 sales of $25.26 million. Earnings fell to a loss of $64.34 million, resulting in a 1.97% decrease from last quarter.

Benzinga

NanoString Technologies Earnings Perspective: Return On Capital Employed

Benzinga Pro data, NanoString Technologies (NASDAQ:NSTG) reported Q1 sales of $31.08 million. Earnings fell to a loss of $39.50 million, resulting in a 34.99% decrease from last quarter.

Benzinga

Why Microsoft Stock Is Moving Lower Today

Microsoft Corp (NASDAQ: MSFT) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

5 Short Squeeze Candidates To Watch This Week: TherapeuticsMD Tops List While This Arts And Crafts Retailer Joins The Leaderboard

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

Benzinga

Looking Into Xenon Pharmaceuticals's Return On Capital Employed

According to Benzinga Pro data, during Q1, Xenon Pharmaceuticals (NASDAQ:XENE) posted sales of $8.77 million. Earnings were up 23.06%, but Xenon Pharmaceuticals still reported an overall loss of $19.67 million.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

InnovAge Holding Earnings Perspective: Return On Invested Capital

Benzinga Pro data, InnovAge Holding (NASDAQ:INNV) reported Q3 sales of $177.36 million. Earnings fell to a loss of $3.16 million, resulting in a 385.53% decrease from last quarter.

Benzinga

Hydrofarm Holdings Group's Return on Invested Capital Insights

Benzinga Pro data, Hydrofarm Holdings Group (NASDAQ:HYFM) reported Q1 sales of $111.38 million. Earnings fell to a loss of $23.30 million, resulting in a 110.9% decrease from last quarter.

Benzinga

Why Nvidia Stock Is Falling

NVIDIA Corp (NASDAQ: NVDA) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

Why Apple Shares Are Sliding

Apple Inc (NASDAQ: AAPL) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

RBC Upgrades Tesla: EV Competition 'Doesn't Overly Concern Us'

Tesla Inc (NASDAQ: TSLA) shares dropped 3.3% on Monday despite the company landing an upgrade on Wall Street. The Analyst: RBC Capital Markets analyst Joseph Spak upgraded Tesla from Sector Perform to Outperform and cut his price target from $1,175 to $1,100.

Benzinga

Endo Inks US Pact For Osteoarthritis Pain Injectable

TLC BioSciences has entered a commercialization agreement with Endo International plc (NASDAQ:ENDP) for the U.S. rights of TLC599, a proprietary BioSeizer sustained-release injectable in Phase 3 development for osteoarthritis pain. Under the agreement signed with Endo's subsidiary Endo Ventures Limited (EVL), TLC will primarily be responsible for developing the product, and EVL for obtaining regulatory…

Benzinga

Gracell Reveals Encouraging Data From Pretreated Multiple Myeloma Patients

Gracell Biotechnologies Inc (NASDAQ:GRCL) announced the updated clinical data on GC012F, an autologous CAR-T therapeutic candidate dual-targeting B-cell maturation antigen (BCMA) and CD19, for relapsed/refractory multiple myeloma (RRMM). From October 2019 to January 2022, 29 heavily pretreated patients were enrolled and treated with a single infusion of GC012F at three dose levels (DL).…

Benzinga

Why Shares Of Astra Space Are Trading Lower

Astra Space, Inc. (NASDAQ: ASTR) shares are trading lower after the company failed to deliver NASA payloads to orbit.

Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Monday.

Benzinga

Here's The Bull, Bear Case For Microsoft Stock As Recession Fears Grip The Tech Sector

Microsoft Corporation (NASDAQ: MSFT) was trading about 2.5% lower in the premarket on Monday, in sympathy with the futures market, which was declining about 2.4%.

Benzinga

Why Electric Last Mile Solutions Stock Is Plunging

Electric Last Mile Solutions Inc (NASDAQ: ELMS) shares are trading significantly lower Monday after the company announced that it plans to file for bankruptcy.

1 … 443 444 445 446

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Advanced Micro Devices

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.